Research Article

Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-κB and Src Protein Kinase Signaling Pathways

  • Mehdi Shakibaei mail,

    Affiliation: Institute of Anatomy, Ludwig-Maximilian-University Munich, Munich, Germany

  • Ali Mobasheri,

    Affiliation: Division of Veterinary Medicine, School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Sutton Bonington Campus, Sutton Bonington, United Kingdom

  • Cora Lueders,

    Affiliation: Department of Thoracic and Cardiovascular Surgery, Laboratory for Tissue Engineering, German Heart Institute Berlin, Berlin, Germany

  • Franziska Busch,

    Affiliation: Institute of Anatomy, Ludwig-Maximilian-University Munich, Munich, Germany

  • Paviz Shayan,

    Affiliation: Investigating Institute of Molecular Biological System Transfer, Tehran, Iran

  • Ajay Goel

    Affiliation: Gastrointestinal Cancer Research Laboratory, Division of Gastroenterology, Baylor Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, United States of America

  • Published: February 22, 2013
  • DOI: 10.1371/journal.pone.0057218

Reader Comments (1)

Post a new comment on this article

Comment from PLOS ONE

Posted by PLoS_ONE_Group on 02 Jul 2013 at 08:09 GMT

It recently came to our attention that the Academic Editor Bharat Aggarwal had collaborated and co-authored different publications with the senior author of the article over the four years that preceded this submission.

In line with the PLOS ONE competing interests policy (, we consider this as a potential conflict of interest. We have therefore asked the Academic Editor Subhash Gautam to carefully evaluate the peer review process of this article. Dr Gautam has confirmed that he is satisfied that the peer review process and the decision for publication are adequate.

Competing interests declared: PLOS ONE Staff